Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury

Nat Med. 2024 Aug;30(8):2349-2355. doi: 10.1038/s41591-024-03019-1. Epub 2024 May 30.

Abstract

Accurately predicting functional outcomes for unresponsive patients with acute brain injury is a medical, scientific and ethical challenge. This prospective study assesses how a multimodal approach combining various numbers of behavioral, neuroimaging and electrophysiological markers affects the performance of outcome predictions. We analyzed data from 349 patients admitted to a tertiary neurointensive care unit between 2009 and 2021, categorizing prognoses as good, uncertain or poor, and compared these predictions with observed outcomes using the Glasgow Outcome Scale-Extended (GOS-E, levels ranging from 1 to 8, with higher levels indicating better outcomes). After excluding cases with life-sustaining therapy withdrawal to mitigate the self-fulfilling prophecy bias, our findings reveal that a good prognosis, compared with a poor or uncertain one, is associated with better one-year functional outcomes (common odds ratio (95% CI) for higher GOS-E: OR = 14.57 (5.70-40.32), P < 0.001; and 2.9 (1.56-5.45), P < 0.001, respectively). Moreover, increasing the number of assessment modalities decreased uncertainty (OR = 0.35 (0.21-0.59), P < 0.001) and improved prognostic accuracy (OR = 2.72 (1.18-6.47), P = 0.011). Our results underscore the value of multimodal assessment in refining neuroprognostic precision, thereby offering a robust foundation for clinical decision-making processes for acutely brain-injured patients. ClinicalTrials.gov registration: NCT04534777 .

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Brain Injuries* / physiopathology
  • Critical Care* / methods
  • Female
  • Glasgow Outcome Scale
  • Humans
  • Male
  • Middle Aged
  • Neuroimaging / methods
  • Prognosis
  • Prospective Studies

Associated data

  • ClinicalTrials.gov/NCT04534777